Wegovy® 0.5 mg is a once-weekly injectable medication containing semaglutide, used for medical weight management in adults with obesity or overweight conditions who also have weight-related health risks. It is part of a structured dosing plan and is not usually a starting dose or final maintenance dose, but a step-up dose used to help the body adjust to treatment.
This medication works by mimicking the GLP-1 hormone, which targets areas of the brain involved in appetite regulation. As a result, it helps to reduce hunger, control food cravings, and increase feelings of fullness, making it easier to consume fewer calories over time when combined with a reduced-calorie diet and regular physical activity.
Wegovy is intended for long-term weight management under medical supervision, not for short-term or cosmetic weight loss. It should be used exactly as prescribed.
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea or constipation
- Stomach discomfort or bloating
- Reduced appetite
These effects are often more noticeable when starting treatment or increasing the dose.
Always consult a healthcare professional before use and follow the prescribed dosing schedule carefully.
Reviews
There are no reviews yet.